U.S. markets closed

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.04-0.11 (-1.54%)
At close: 4:00PM EST

7.12 +0.08 (1.14%)
After hours: 7:54PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/27/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
87.36M39.50M65.64M16.54M33.99M
Enterprise Value 3
76.67M30.09M60.32M9.55M30.49M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
4.422.453.680.971.98
Price/Book (mrq)
10.40N/A12.562.435.29
Enterprise Value/Revenue 3
7.4110.3926.646.518.20
Enterprise Value/EBITDA 6
-5.5811.49-5.21-4.12-12.28

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 343.57%
S&P500 52-Week Change 323.92%
52 Week High 314.98
52 Week Low 32.25
50-Day Moving Average 39.19
200-Day Moving Average 36.10

Share Statistics

Avg Vol (3 month) 3394.58k
Avg Vol (10 day) 3490.17k
Shares Outstanding 512.22M
Float 7.3M
% Held by Insiders 110.54%
% Held by Institutions 118.91%
Shares Short (Feb 11, 2021) 4205.74k
Short Ratio (Feb 11, 2021) 40.36
Short % of Float (Feb 11, 2021) 41.81%
Short % of Shares Outstanding (Feb 11, 2021) 41.68%
Shares Short (prior month Jan 14, 2021) 4247.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 24, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -178.17%
Operating Margin (ttm)-144.76%

Management Effectiveness

Return on Assets (ttm)-37.81%
Return on Equity (ttm)-281.81%

Income Statement

Revenue (ttm)8.88M
Revenue Per Share (ttm)1.24
Quarterly Revenue Growth (yoy)-39.40%
Gross Profit (ttm)5.07M
EBITDA -12.24M
Net Income Avi to Common (ttm)-15.82M
Diluted EPS (ttm)-2.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.86M
Total Cash Per Share (mrq)1.54
Total Debt (mrq)3.86M
Total Debt/Equity (mrq)86.96
Current Ratio (mrq)3.70
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A